Donnelly B Kevin

DB

Statistics

Publications

2

Citations

32

H-Index

2

Active since

2020

Donnelly B Kevin is an author at Eli Lilly (Singapore) specializing in tau post-translational modifications, neurodegenerative disease pharmacotherapy, and pharmacology.

Publications per year

2020–2020

2

Publications

2